The PGY1 Pharmacy Residency - Ambulatory Focus Program was established in 2012 and accredited by ASHP in 2014. The program provides an environment for comprehensive education and training in drug therapy and disease state management for patients in a collaborative ambulatory setting. The PGY1 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide-range of conditions, eligible for board certification, and eligible for post-graduate year two (PGY2) pharmacy residency training.
Required rotations: • Orientation (1 month) • Drug Information and Clinical Skills Development (1 month) • Anticoagulation Clinic and On-Call (Longitudinal) • Focused Care Transitions (1 month) • Advanced Heart Failure Clinic (1 month) • Ambulatory Oncology Clinic (1 month) • Emergency Medicine – Urgent Care (1 month) • Internal Medicine Clinic (1 month) • Pharmaceutical Care Services and Administration (1 month) • Practice Management (Longitudinal) • Preventative and Wellness Programs (Longitudinal-Blood Pressure Screenings, Health Fairs, Immunizations) • Outpatient Pharmacy Staffing (Longitudinal)
Elective rotation options - 3 months • Human Immunodeficiency Virus (HIV) Clinic • Solid Organ Transplant Clinic • Diabetes Specialty & Chronic Care Center • Outpatient Pharmacy Practice Management
The specific program for each resident varies based upon the resident’s goals, interests, and previous experience. However, all residents are required to complete the above core rotations. The required rotations can be repeated and tailored to resident interests as an elective, or the resident may select from elective rotations experiences. A longitudinal elective experience in the Teaching Certificate Program through Duquesne University School of Pharmacy is also available.
Applications will be accepted through January 2, 2020. Application materials should include the following: • Letter of intent • Residency Interest Form • Curriculum vitae • Three professional letters of recommendation • Academic transcript
An on-site interview is also required. The residency commences by July 1.
Applicants must be eligible for graduation or have graduated from an ACPE accredited school of pharmacy and must be licensed or eligible for Pennsylvania pharmacist licensure. Information on Pennsylvania pharmacist licensure eligibility can be found at:
Allegheny General Hospital (AGH) is an academic medical center serving Pittsburgh and the surrounding five-state area. The hospital annually admits more than 24,000 patients, and has nearly 800 physicians and approximately 5,000 employees that share AGH's commitment to excellence in patient care, medical education and research. AGH is the flagship tertiary care hospital in the Allegheny Health Network (AHN).
The AGH Department of Pharmacy provides on-site outpatient pharmacy services and 24-hour inpatient comprehensive pharmacy services utilizing a decentralized, computerized unit-dose drug distribution system and intravenous admixture programs in a newly remodeled pharmacy. Other pharmacy services include drug information, computerized inventory control and procurement systems, integrated drug use review, and quality improvement. Extensive in-service education and staff development programs are also available.
The AGH Pharmacy Residency Programs consists of 19 residents within eight-different residency programs. PGY1 programs include Acute Care and Ambulatory Focused residencies. PGY2 programs include Ambulatory Care, Cardiology, Critical Care, Oncology, and Infectious Di...seases residencies. A combined PGY1-PGY2 Health-System Pharmacy Administration Residency Program with MPH at the University of Pittsburgh Graduate School of Public Health is also available. Residents receive a stipend of $44,000 for PGY1 and $46,000 for PGY2 with medical, prescription, dental, vision, disability, and life-insurance benefits. Thirteen paid days off are provided during the residency year outside of days to attend approved conferences.